Clinical implications of pharmacogenomics of statin treatment

被引：120
|
作者：
Mangravite, L. M.
Thorn, C. F.
Krauss, R. M.
机构：
[1] Childrens Hosp Oakland, Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 06期
关键词：
D O I：
10.1038/sj.tpj.6500384
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：360 / 374
页数：15
相关论文
共 50 条
  • [31] Statin Toxicity Mechanistic Insights and Clinical Implications
    Ward, Natalie C.
    Watts, Gerald F.
    Eckel, Robert H.
    CIRCULATION RESEARCH, 2019, 124 (02) : 328 - 350
  • [32] Statin safety and drug interactions: Clinical implications
    Bottorff, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A): : 27C - 31C
  • [33] Beyond the laboratory - Clinical implications for statin pleiotropy
    Halcox, JPJ
    Deanfield, JE
    CIRCULATION, 2004, 109 (21) : 42 - 48
  • [34] Statin withdrawal: Clinical implications and molecular mechanisms
    Cubeddu, Luigi X.
    Seamon, Matthew J.
    PHARMACOTHERAPY, 2006, 26 (09): : 1288 - 1296
  • [35] Clinical implications of statin event trials.
    Goldberg A.C.
    Current Atherosclerosis Reports, 2002, 4 (5) : 337 - 342
  • [36] Statin Pharmacogenomics: Lipid Response and Cardiovascular Outcomes
    Kerola T.
    Lehtimäki T.
    Kähönen M.
    Nieminen T.
    Current Cardiovascular Risk Reports, 2010, 4 (2) : 150 - 158
  • [37] Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications
    Genvigir, Fabiana Dalla Vecchia
    Dagli-Hernandez, Carolina
    Hirata, Thiago Dominguez Crespo
    Zhou, Yitian
    Lauschke, Volker M.
    Hirata, Mario Hiroyuki
    Hirata, Rosario Dominguez Crespo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (13) : 1263 - 1275
  • [38] Pharmacogenomics and perioperative medicine: implications for modern clinical practice Reply
    Kim, Jerry H.
    Schwinn, Debra A.
    Landau, Ruth
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2009, 56 (06): : 468 - 468
  • [39] Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications
    Geng, Ting-Ting
    Jafar, Tazeen H.
    KIDNEY360, 2022, 3 (02): : 204 - 207
  • [40] Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications
    Guillemette, C.
    Levesque, E.
    Rouleau, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (03) : 324 - 339
12345